Box 1 Key components of nurse-managed trial exit intervention

From: A randomised controlled trial of nurse-managed trial conclusion following early phase cancer trial participation

Drug trial exit interview

 •Debriefing of decision around completion/withdrawal

 •Explanation of further follow-up support

Information leaflet

 •A thank you for participating in the trial

 •Latest information about the drug being tested

 •News about other participants

 •Details about the participant's contribution to cancer research

 •Available support after drug trial participation

 •Details on further follow-up

Telephone follow-up at 2 weeks postdrug trial exit

 •Enquiry as to general health

 •Identification of unmet information needs

 •Emotional support if required

Back to article page